Conventional methods of detecting antibody to influenza virus are not sufficiently sensitive to quantitate low levels of viral antibody. For example, vaccinees who received attenuated strains of influenza A virus were resistant to wild-type virus challenge in the absence of detectable serum antibody to the challenge virus (13, 20, 27) . Levels of antibody in the nasal secretions regularly tend to be quite low, yet such secretions are of principal interest in studying the immunology of resistance to influenza virus. Thus, there is a need to develop more sensitive techniques capable of detecting low levels of antibody in serum and nasal secretions. Recently, enzyme-linked immunosorbent assay (ELISA) methodology has been used to measure the immune response to influenza A virus (1, 3, 8, 10, 17) . However, in these assays, whole virus has been used as an antigen which detects antibodies to both the subtype-specific surface antigens and the type-specific internal antigens (8) . Immunity to the hemagglutinin (HA) and neuraminidase surface glycoproteins correlates with resistance, whereas immunity to the internal type-specific antigens does not (15, 23) . Therefore, it is important to develop a sensitive ELISA that will detect antibody to the epidemiologically important surface antigens of the influenza A virus (5) . In this paper, an HA-specific ELISA is described which can be used to measure antibody in serum and nasal wash specimens.
MATERIALS AND METHODS
Clinical specimens. Live wild-type and attenuated influenza A viruses were given to volunteers as part of a vaccine development program (2). Pre-and postinfection sera and nasal washes were obtained from volunteers or patients who were infected with one of the following agents: (i) A/Hong Kong/123/77 (HlNl) wild-type virus, 104`50%o tissue culture infectious dose (TCIDso) (adults) (16) ; (ii) A/Alaska/6/77 (H3N2) wild-type virus, 1042 TCID5o (adults) (14) ; (iii) influenza B wild-type virus, antigenically similar to B/ Hong Kong/8/73 virus (sera from children who had natural infections with influenza B virus were kindly supplied by H.-Y. Kim, Childrens National Medical Center, Washington, D.C); or (iv) A/Udorn/307/72 (H3N2) wild-type, 104. TCID5o, or vaccine virus, 1060 to 107°TCID5o (adults) (20) . Nasal wash specimens
The tube neutralization titer test to detect antibodies in nasal wash speciemns was described previously (20) .
Purification of HA. Influenza virus grown in the allantoic cavity of embryonated eggs was banded twice in sucrose (12) , and the HA was extracted and purified as described previously (19) . The purified HA was 95 to 98% free of other influenza antigens. Hyperimmune antiserum raised in sheep to the purified HA contains antibody only to the HA antigen (19) The ELISA was used to characterize the specificity ofrabbit anti-human globulin. In such assays a purified human immunoglobulin (IgG, IgA, IgM, or IgE) was diluted in carbonate buffer (pH 9.8) to a concentration of 100 ng/ml. One hundred microliters of this antigen solution was added to the wells of a microtiter plate which was incubated at 4°C for at least 14 h. Control wells received only carbonate buffer. The outermost row of wells of each plate was not used. A solution containing phosphate-buffered saline with 0.5 ml of polysorbate (PBS-Tween) per liter and 1% fetal calf serum was used to dilute all serum or nasal wash specimens. After three washes with PBS-Tween, 100 ,ul of diluted rabbit anti-human immunoglobulin was added to antigen-containing and control wells and was serially diluted as described previously (17) . The plates were then incubated at room temperature overnight.
After three washes, 100 pl of a predetermined dilution of goat anti-rabbit serum conjugated with alkaline phosphatase (Northeast Biomedicals, South Windham, Maine) was added, and the plates were incubated overnight at room temperature. The plates were then washed three times, and 100 pl ofp-nitrophenol phosphate substrate (1 mg/ml; Sigma 104; Sigma Chemical Co., St. Louis, Mo.) dissolved in 10% diethanolamine buffer was added. After 2 h at 37°C, a multichannel spectrophotometer (Flow Laboratories, Inc., McLean, Va.) was used to measure the yellow chromogen produced by enzymatic cleavage of the substrate. The ELISA titers were calculated by the conventional positive-over-negative (P/N) method in which the endpoint was the highest dilution that gave a P/N ratio equal to or >2. In such a calculation, the optical density of an antigen-containing well (positive) is divided by the optical density of the respective control well (negative).
Similarly, a one-step ELISA was designed to detect antibodies in serum against the purified HA. Purified HA, stored frozen at -70°C, was diluted in carbonate buffer to a concentration of 100 ng/ml. One hundred microliters was added to wells, and the plate was incubated overnight at 4°C. Control wells received only carbonate buffer. For each assay a new sample of frozen HA was used. The test was then performed as described above with the subsequent addition of the following sequence of reagents: human serum; goat anti-human IgG conjugated with alkaline phosphatase (Miles Laboratories, Inc., Elkhart, Ind.); and, finally, substrate. After the addition of each reagent, the plate was incubated overnight at room temperature, except when substrate was added; in this instance the plate was incubated at 37°C for 2 h. The titer of anti-HA antibody was determined by the P/N method described above. The dilutions of reagents were chosen, in part, to give optical density readings in control wells of <0.10.
A two-step ELISA was developed to measure the immunoglobulin isotype (class) specificity of the anti-HA response. In this assay the sequence of reagents from the solid phase up consisted of (i) purified HA,
(ii) human serum or nasal wash, (iii) a rabbit antihuman immunoglobulin serum, (iv) goat anti-rabbit serum conjugated with alkaline phosphatase, and (v) To investigate whether the HAI assay and ELISA were measuring antibody to the same antigen, 24 sera were titrated in both assays, and their respective titers were correlated (Fig. 1) <100 102,400 <100 Anti-FAB 640,000 2,560,000 640,000 25,000 Normal <100 <100 <100 <100 'A total of 0.1 ml of a solution of immunoglobulin containing 100 ng/ml was applied to each well. 20 ,000. At the dilution of rabbit anti-human IgG used, little, if any, cross-reaction with IgM would be expected.
The results of the HAI, one-step ELISA, and two-step ELISA serum antibody response of volunteers infected with the A/Udorn/72 virus are summarized in Table 3 . The IgG one-and two-step ELISA were both more sensitive than the HAI response by a magnitude similar to that shown in Table 1 . Rises to the H3 HA were detected in these eight serum pairs in the IgG, IgA, and IgM immunoglobulin classes. The levels of antibody present and the magnitude of the rise were greatest using rabbit anti-IgG or anti-FAB sera. Sera from children without previous experience with influenza virus had oneand two-step ELISA anti-HA titers of <1:20. Since influenza A virus usually localizes in the respiratory tract, it is important to be able to quantitate the influenza A virus antibody response in respiratory secretions. Eleven pairs of pre-and post-inoculation nasal washes were selected for analysis from volunteers who were infected with A/Udorn/72 virus and who showed a spectrum of neutralizing antibody responses (Table 4) (20) . For determination of antibody in nasal washes, dilutions of 1:5,000 of rabbit anti-human IgA antibody and 1:20,000 of anti-IgG were used since, at this concentration, the optical density in the control wells (which included all of the sequence of reagents except HA) was <0.10. The post-inoculation levels of ELISA anti-HA antibody were highest in the IgA isotype, and more rises were documented using this anti-IgA serum. Significant quantities of IgG H3 antibody were present with only low quantities of IgM H3 antibody. The log2 fold rise of the anti-IgA ELISA was 1.5 log2 greater than that detected by the neutralization test, and the slope (Fig. 2) was >1. These findings suggested a greater sensitivity of the IgA ELISA. Unfortunately, there was only enough of each nasal wash specimen available for testing undiluted in the neutralization assay, but not enough for the ELISA. Consequently, the 1.5 log2 difference in sensitivity is likely to be an underestimate of the comparative sensitivities of the neutralization assay and the IgA ELISA. Again, there was good correlation between neutralizing antibody titers and IgA ELISA titers (Fig. 2) 
